Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000450:Aldosterone / Q000378:metabolism*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001794:Blood Pressure; D002216:Captopril / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D007668:Kidney / Q000502:physiology*; D009842:Oligopeptides / Q000627:therapeutic use; D051381:Rats; D012079:Renal Circulation; D012084:Renin-Angiotensin System; D012504:Saralasin / Q000627:therapeutic use; D013722:Teprotide; D000092502:Renin Inhibitors
D000319:Adrenergic beta-Antagonists; D000450:Aldosterone; D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D009842:Oligopeptides; D012504:Saralasin; D013722:Teprotide; D000092502:Renin Inhibitors